Drug resistance remains one of the leading bottlenecks contributing to unsatisfactory therapeutic outcomes and eventual treatment failure during clinical cancer chemotherapy, and abundant preclinical evidence has confirmed that abnormally elevated NNMT expression is closely correlated with acquired drug resistance across various solid and hematologic malignancies
Ideal for low-dose researchers on 0.25mg or those doing quarter-milligram doses
Hormonal imbalances: Some weight loss medications, including semaglutide, can impact hormone levels, indirectly affecting muscle maintenance and growth
Yes, sleepiness and fatigue are reported by some patients during the first few weeks of GLP-1 therapy, especially during dose escalation
As more studies and treatment options, become available, the hope is that well get to precision therapy where we can identify which agents are most effective for which complications